STOCK TITAN

[Form 4] Teradyne, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Reporting person: Gregory Stephen Smith, who serves as President and CEO and a director of Teradyne, Inc. (TER), reported an insider sale on Form 4. The transaction occurred on 08/12/2025 and was reported on a Form 4 signed by an attorney-in-fact on 08/14/2025. The filing shows 554 shares of Teradyne common stock were sold at a price of $106 per share pursuant to a pre-established Rule 10b5-1 sales plan adopted on February 4, 2025. After the reported sale, the filing shows the reporting person beneficially owns 96,992.995 shares directly.

Dichiarante: Gregory Stephen Smith, che ricopre la carica di Presidente e CEO e fa parte del consiglio di amministrazione di Teradyne, Inc. (TER), ha segnalato una vendita da insider nel Form 4. La transazione è avvenuta il 08/12/2025 ed è stata riportata in un Form 4 firmato da un procuratore il 08/14/2025. Il documento indica che 554 azioni ordinarie di Teradyne sono state vendute a $106 per azione ai sensi di un piano di vendita predefinito conforme alla Regola 10b5-1 adottato il 4 febbraio 2025. Dopo la vendita segnalata, il documento mostra che il dichiarante possiede direttamente in modo beneficiario 96,992.995 azioni.

Declarante: Gregory Stephen Smith, quien se desempeña como presidente y CEO y es director de Teradyne, Inc. (TER), informó una venta de insider en el Formulario 4. La operación se realizó el 08/12/2025 y fue registrada en un Formulario 4 firmado por un apoderado el 08/14/2025. El documento indica que se vendieron 554 acciones ordinarias de Teradyne a $106 por acción conforme a un plan de ventas preestablecido bajo la Regla 10b5-1 adoptado el 4 de febrero de 2025. Tras la venta reportada, el formulario muestra que el declarante posee beneficiariamente de forma directa 96,992.995 acciones.

보고자: Gregory Stephen Smith는 Teradyne, Inc.(TER)의 사장 겸 CEO이자 이사로서 Form 4에 내부자 매도 거래를 보고했습니다. 거래는 08/12/2025에 발생했으며, 위임권한을 받은 대리인이 서명한 Form 4에 08/14/2025에 보고되었습니다. 제출서류에 따르면 사전 설정된 Rule 10b5-1 매도 계획(2025년 2월 4일 채택)에 따라 Teradyne 보통주 554주가 주당 $106매도되었습니다. 보고된 매도 후, 제출서류는 보고자가 직접적으로 유익하게 소유한 주식이 96,992.995주라고 표시하고 있습니다.

Personne déclarante : Gregory Stephen Smith, qui occupe les fonctions de président et CEO et est administrateur de Teradyne, Inc. (TER), a signalé une cession d'initié dans un Formulaire 4. La transaction a eu lieu le 08/12/2025 et a été déclarée dans un Formulaire 4 signé par un mandataire le 08/14/2025. Le dépôt indique que 554 actions ordinaires de Teradyne ont été vendues au prix de $106 par action en vertu d'un plan de vente préétabli selon la règle 10b5-1 adopté le 4 février 2025. Après la vente signalée, le dépôt indique que la personne déclarante détient directement à titre bénéficiaire 96,992.995 actions.

Meldende Person: Gregory Stephen Smith, der als President und CEO sowie als Direktor von Teradyne, Inc. (TER) tätig ist, meldete einen Insiderverkauf in Formular 4. Die Transaktion erfolgte am 08/12/2025 und wurde in einem Formular 4 gemeldet, das am 08/14/2025 von einem Bevollmächtigten unterzeichnet wurde. Die Einreichung weist aus, dass 554 Stammaktien von Teradyne gemäß einem vorab festgelegten Verkaufsplan nach Regel 10b5-1, der am 4. Februar 2025 angenommen wurde, zu einem Preis von $106 pro Aktie verkauft wurden. Nach dem gemeldeten Verkauf zeigt die Einreichung, dass die meldende Person unmittelbar wirtschaftlich begünstigt 96,992.995 Aktien besitzt.

Positive
  • Sale executed under a documented Rule 10b5-1 plan adopted on February 4, 2025, indicating pre-planned disposition
  • Full disclosure provided on Form 4, including transaction date, price, and post-transaction beneficial ownership of 96,992.995 shares
Negative
  • Reporting person disposed of 554 shares of Teradyne common stock on 08/12/2025
  • Transaction recorded at $106 per share, reducing the reporting person’s direct holdings

Insights

TL;DR: A routine 10b5-1 sale by Teradyne's CEO of a small number of shares; filing provides clear disclosure of amount and remaining ownership.

The Form 4 documents a single non-derivative sale by Gregory S. Smith executed under a 10b5-1 plan, which typically indicates the trade was pre-planned and not opportunistic. The sale of 554 shares at $106 is explicitly disclosed along with the post-transaction direct beneficial ownership of 96,992.995 shares. For most investors, this filing is a transparency item rather than evidence of a material change in ownership or control.

TL;DR: The transaction follows a documented 10b5-1 plan and was properly reported on Form 4, reflecting compliance with insider-trading protocols.

The disclosure states the shares were sold pursuant to a sales plan adopted on February 4, 2025, satisfying Rule 10b5-1 affirmative defense conditions as noted in the explanation. The Form 4 is signed by an attorney-in-fact, indicating procedural adherence. The filing contains no additional governance events or changes in officer/director status.

Dichiarante: Gregory Stephen Smith, che ricopre la carica di Presidente e CEO e fa parte del consiglio di amministrazione di Teradyne, Inc. (TER), ha segnalato una vendita da insider nel Form 4. La transazione è avvenuta il 08/12/2025 ed è stata riportata in un Form 4 firmato da un procuratore il 08/14/2025. Il documento indica che 554 azioni ordinarie di Teradyne sono state vendute a $106 per azione ai sensi di un piano di vendita predefinito conforme alla Regola 10b5-1 adottato il 4 febbraio 2025. Dopo la vendita segnalata, il documento mostra che il dichiarante possiede direttamente in modo beneficiario 96,992.995 azioni.

Declarante: Gregory Stephen Smith, quien se desempeña como presidente y CEO y es director de Teradyne, Inc. (TER), informó una venta de insider en el Formulario 4. La operación se realizó el 08/12/2025 y fue registrada en un Formulario 4 firmado por un apoderado el 08/14/2025. El documento indica que se vendieron 554 acciones ordinarias de Teradyne a $106 por acción conforme a un plan de ventas preestablecido bajo la Regla 10b5-1 adoptado el 4 de febrero de 2025. Tras la venta reportada, el formulario muestra que el declarante posee beneficiariamente de forma directa 96,992.995 acciones.

보고자: Gregory Stephen Smith는 Teradyne, Inc.(TER)의 사장 겸 CEO이자 이사로서 Form 4에 내부자 매도 거래를 보고했습니다. 거래는 08/12/2025에 발생했으며, 위임권한을 받은 대리인이 서명한 Form 4에 08/14/2025에 보고되었습니다. 제출서류에 따르면 사전 설정된 Rule 10b5-1 매도 계획(2025년 2월 4일 채택)에 따라 Teradyne 보통주 554주가 주당 $106매도되었습니다. 보고된 매도 후, 제출서류는 보고자가 직접적으로 유익하게 소유한 주식이 96,992.995주라고 표시하고 있습니다.

Personne déclarante : Gregory Stephen Smith, qui occupe les fonctions de président et CEO et est administrateur de Teradyne, Inc. (TER), a signalé une cession d'initié dans un Formulaire 4. La transaction a eu lieu le 08/12/2025 et a été déclarée dans un Formulaire 4 signé par un mandataire le 08/14/2025. Le dépôt indique que 554 actions ordinaires de Teradyne ont été vendues au prix de $106 par action en vertu d'un plan de vente préétabli selon la règle 10b5-1 adopté le 4 février 2025. Après la vente signalée, le dépôt indique que la personne déclarante détient directement à titre bénéficiaire 96,992.995 actions.

Meldende Person: Gregory Stephen Smith, der als President und CEO sowie als Direktor von Teradyne, Inc. (TER) tätig ist, meldete einen Insiderverkauf in Formular 4. Die Transaktion erfolgte am 08/12/2025 und wurde in einem Formular 4 gemeldet, das am 08/14/2025 von einem Bevollmächtigten unterzeichnet wurde. Die Einreichung weist aus, dass 554 Stammaktien von Teradyne gemäß einem vorab festgelegten Verkaufsplan nach Regel 10b5-1, der am 4. Februar 2025 angenommen wurde, zu einem Preis von $106 pro Aktie verkauft wurden. Nach dem gemeldeten Verkauf zeigt die Einreichung, dass die meldende Person unmittelbar wirtschaftlich begünstigt 96,992.995 Aktien besitzt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Smith Gregory Stephen

(Last) (First) (Middle)
TERADYNE, INC.
600 RIVERPARK DRIVE

(Street)
NORTH READING MA 01864

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TERADYNE, INC [ TER ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/12/2025 S(1) 554 D $106 96,992.995 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on February 4, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
/s/ Ryan E. Driscoll, Attorney-in-Fact 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who reported the transaction in the Form 4 for TER?

The reporting person is Gregory Stephen Smith, identified as President and CEO and a director of Teradyne, Inc.

What transaction did TER insider Gregory Smith report?

He reported the sale of 554 shares of Teradyne common stock on 08/12/2025 at a price of $106 per share.

Was the sale by the TER reporting person part of a 10b5-1 plan?

Yes. The Form 4 states the shares were sold pursuant to a sales plan adopted on February 4, 2025 intended to comply with Rule 10b5-1.

How many shares did the reporting person own after the reported transaction?

The filing shows 96,992.995 shares were beneficially owned by the reporting person following the reported transaction.

When was the Form 4 signed and filed?

The signature on the form by an attorney-in-fact, Ryan E. Driscoll, is dated 08/14/2025.
Teradyne

NASDAQ:TER

TER Rankings

TER Latest News

TER Latest SEC Filings

TER Stock Data

17.76B
158.63M
0.27%
99.86%
5%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
NORTH READING